Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Metastases, Neoplasm
Interventions: DRUG: Capecitabine|DRUG: Exisulind
Sponsor: M.D. Anderson Cancer Center
Collaborators: Cell Pathways